VYNE Therapeutics Inc (VYNE)

[jugs]

There's nothing new in this low quality representation of previously disseminated headlines.

Share ALWAYS rise following a reverse split as that's the nature and intent of a reverse split. That said, I expect the pre-split share price to drop, providing a much improved buy point in weeks following the split.

The link fails to mention the end of year launch of Zilxi, MNLO's second recently approved drug--- by the FDA. That omission is unpardonable. This is the drug providing relief for sufferers of rosacea and will enjoy a sizable market to address. Also, Amzeeq is already doing very well in the marketplace. Alas, no mention of these all-important developments.

As I said, terribly inadequate publications being cited.